beta-Casomorphin-immunoreactivity in the brain stem of the human infant

A Pasi1, H Mahler, N Lansel

  • 1Endorphin Research Laboratories, University of Zürich, Switzerland.

Research Communications in Chemical Pathology and Pharmacology
|June 1, 1993
PubMed

Insights

Beta-casomorphin-8 (BC8) immunoreactivity was found in infant brain stems. These findings suggest beta-casomorphins may enter the brain and influence physiological regulation.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pediatric Research

Background:

  • Beta-casomorphins are opioid-active peptides derived from casein.
  • Their presence and function in the infant brain are not fully understood.

Purpose of the Study:

  • To investigate the presence and distribution of beta-casomorphin-8 immunoreactivity (BCIR) in the infant brain stem.
  • To explore the potential role of beta-casomorphins in central physiological regulation.

Main Methods:

  • Peptide extraction and reversed-phase high-performance liquid chromatography (RP-HPLC).
  • Radioimmunoassay (RIA) using an antibody specific to human beta-casomorphin-8 (BC8).
  • Analysis of brain stem tissue from eight infants.

Main Results:

  • BCIR was detected in nineteen distinct areas of the mesencephalon, pons cerebri, and medulla oblongata.
  • BCIR levels showed a rostrocaudally increasing gradient.
  • The detected BCIR was attributed to BC8 and/or its congeners.

Conclusions:

  • Beta-casomorphins are present in the infant brain stem.
  • Specific transport mechanisms may facilitate blood-to-brain entry of beta-casomorphins.
  • Beta-casomorphins may play a role in the central regulation of physiological phenomena.

Related Concept Videos